scispace - formally typeset
M

Miia Kovalainen

Researcher at University of Oulu

Publications -  23
Citations -  865

Miia Kovalainen is an academic researcher from University of Oulu. The author has contributed to research in topics: Drug carrier & Adipose tissue. The author has an hindex of 12, co-authored 22 publications receiving 748 citations. Previous affiliations of Miia Kovalainen include Oulu University Hospital & University of Eastern Finland.

Papers
More filters
Journal ArticleDOI

Immobilization of protein-coated drug nanoparticles in nanofibrillar cellulose matrices--enhanced stability and release.

TL;DR: It was demonstrated that by enclosing the functionalized protein coated itraconazole nanoparticles to the external nanofibrillar cellulose matrix notably increased their storage stability and enhanced the in vivo performance of the drug.
Journal ArticleDOI

Distinct Effects of Calorie Restriction and Resveratrol on Diet-Induced Obesity and Fatty Liver Formation

TL;DR: CR provided superior protection against diet-induced obesity and fatty liver formation as compared to resveratrol, and the effects were associated with increased physical activity and ameliorated adipose tissue inflammation.
Journal ArticleDOI

Mesoporous Silicon (PSi) for Sustained Peptide Delivery: Effect of PSi Microparticle Surface Chemistry on Peptide YY3-36 Release

TL;DR: Improved bioavailability of PYY3-36 via TOPSi and the importance of surface chemistry of PSi on peptide release are clearly demonstrated and PSi represents a promising sustained and tailorable release system for PYY 3-36.
Journal ArticleDOI

Nanocrystal-based per-oral itraconazole delivery: superior in vitro dissolution enhancement versus Sporanox® is not realized in in vivo drug absorption.

TL;DR: In this study, solid oral nanocrystal delivery systems of itraconazole were formulated to enhance the oral bioavailability of the very poorly soluble drug and out-performed the nanocrystalline formulations in vivo, but the efficient in vitro dissolution enhancement of thenanocrystal formulations compared to Sporanox® was not realized in in vivo drug absorption.